• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

管理式医疗组织提供戒烟治疗的财务影响。

The financial implications of coverage of smoking cessation treatment by managed care organizations.

作者信息

Warner Kenneth E, Mendez David, Smith Dean G

机构信息

Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI 48109-2029, USA.

出版信息

Inquiry. 2004 Spring;41(1):57-69. doi: 10.5034/inquiryjrnl_41.1.57.

DOI:10.5034/inquiryjrnl_41.1.57
PMID:15224960
Abstract

This paper presents results from a simulation of the financial impact and cost effectiveness of smoking cessation in a hypothetical managed care organization (MCO), using data from three large managed care organizations and from existing literature. With base-case assumptions and a market cost of capital, at five years, coverage of cessation services costs an MCO dollars .61 per member per month (PMPM). In a steady-state situation, net cost is dollars .41 PMPM. Both values include altered medical expenditures and MCO revenue patterns attributable to coverage-induced cessation. Quitters gain an average of 7.1 years of life, with a direct coverage cost of dollars 3,417 for each life-year saved. Coverage of cost-effective programs by MCOs should be strongly encouraged.

摘要

本文利用来自三个大型管理式医疗组织的数据以及现有文献,展示了在一个假设的管理式医疗组织(MCO)中戒烟的财务影响和成本效益模拟结果。基于基本假设和市场资本成本,在五年时,戒烟服务的覆盖成本为每个成员每月0.61美元(PMPM)。在稳态情况下,净成本为0.41美元PMPM。这两个值都包括因覆盖导致戒烟而改变的医疗支出和MCO收入模式。戒烟者平均多活7.1年,每挽救一个生命年的直接覆盖成本为3417美元。应大力鼓励MCO覆盖具有成本效益的项目。

相似文献

1
The financial implications of coverage of smoking cessation treatment by managed care organizations.管理式医疗组织提供戒烟治疗的财务影响。
Inquiry. 2004 Spring;41(1):57-69. doi: 10.5034/inquiryjrnl_41.1.57.
2
Smoking cessation services: coverage and utilization.
Manag Care Interface. 1999 Aug;12(8):81-2.
3
Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.成本、承诺与地区性:营利性与非营利性健康保险计划的比较
Inquiry. 2004 Summer;41(2):116-29. doi: 10.5034/inquiryjrnl_41.2.116.
4
Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.美国医疗保健政策与研究署(AHCPR)戒烟指南中临床实践建议的成本效益。美国医疗保健政策与研究署。
JAMA. 1997 Dec 3;278(21):1759-66.
5
Estimated Budget Impact of Adopting the Affordable Care Act's Required Smoking Cessation Coverage on United States Healthcare Payers.采用《平价医疗法案》规定的戒烟保险对美国医疗保健支付方的预计预算影响。
Adv Ther. 2017 Jan;34(1):156-170. doi: 10.1007/s12325-016-0446-y. Epub 2016 Nov 25.
6
The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.吸烟史框架:说明戒烟尝试、戒烟方法和新烟民对吸烟流行率、挽救的预期寿命、节省的医疗费用、规划成本、成本效益和投资回报的影响。
Am J Health Promot. 2011 Sep-Oct;26(1):e11-23. doi: 10.4278/ajhp.101014-QUAN-337.
7
The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.第二代抗组胺药从处方药转换为非处方药后支付方政策的经济影响。
Value Health. 2004 Jul-Aug;7(4):402-12. doi: 10.1111/j.1524-4733.2004.74003.x.
8
Value for the money spent? Exploring the relationship between expenditures, insurance adequacy, and access to care for publicly insured children.花钱是否值得?探讨公共保险儿童支出、保险充足性与获得医疗服务之间的关系。
Matern Child Health J. 2012 Apr;16 Suppl 1:S51-60. doi: 10.1007/s10995-012-0994-y.
9
The cost-effectiveness of the English smoking treatment services: evidence from practice.英国吸烟治疗服务的成本效益:实践证据。
Addiction. 2005 Apr;100 Suppl 2:70-83. doi: 10.1111/j.1360-0443.2005.01071.x.
10
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.希腊伐伦克林与安非他酮、尼古丁替代疗法和非药物戒烟的成本效益比较。
Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.

引用本文的文献

1
Evaluation of an integrated treatment to address smoking cessation and anxiety/depressive symptoms among people living with HIV: Study protocol for a randomized controlled trial.评估一种综合治疗方案对 HIV 感染者戒烟和焦虑/抑郁症状的效果:一项随机对照试验的研究方案。
Contemp Clin Trials. 2021 Jul;106:106420. doi: 10.1016/j.cct.2021.106420. Epub 2021 Apr 30.
2
A Magic Bullet? The Potential Impact of E-Cigarettes on the Toll of Cigarette Smoking.电子烟:香烟危害的终结者?
Nicotine Tob Res. 2021 Mar 19;23(4):654-661. doi: 10.1093/ntr/ntaa160.
3
How much of the future mortality toll of smoking can be avoided?
吸烟导致的未来死亡人数中有多少是可以避免的?
Tob Control. 2020 Jun 16. doi: 10.1136/tobaccocontrol-2019-055530.
4
Cost-Effectiveness of Using Mass Media to Prevent Tobacco Use among Youth and Young Adults: The FinishIt Campaign.利用大众媒体预防青少年和青年使用烟草的成本效益:芬兰戒烟运动。
Int J Environ Res Public Health. 2019 Nov 6;16(22):4312. doi: 10.3390/ijerph16224312.
5
Smoking cessation for the neurologic patient.神经科患者戒烟
Neurol Clin Pract. 2012 Jun;2(2):112-121. doi: 10.1212/CPJ.0b013e31825a7812.
6
Medical costs and quality-adjusted life years associated with smoking: a systematic review.与吸烟相关的医疗成本和质量调整生命年:一项系统综述。
BMC Public Health. 2016 Jul 27;16:646. doi: 10.1186/s12889-016-3319-z.
7
Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.西班牙慢性阻塞性肺疾病患者戒烟药物资金的预算影响分析。
Int J Chron Obstruct Pulmon Dis. 2015 Sep 24;10:2027-36. doi: 10.2147/COPD.S87597. eCollection 2015.
8
Reimbursing dentists for smoking cessation treatment: views from dental insurers.为牙医的戒烟治疗提供报销:来自牙科保险公司的观点。
Nicotine Tob Res. 2012 Oct;14(10):1180-6. doi: 10.1093/ntr/nts010. Epub 2012 Mar 1.
9
Randomized controlled trial of mailed Nicotine Replacement Therapy to Canadian smokers: study protocol.邮寄尼古丁替代疗法对加拿大吸烟者的随机对照试验:研究方案。
BMC Public Health. 2011 Sep 28;11:741. doi: 10.1186/1471-2458-11-741.
10
[Pharmacotherapeutic treatment strategies for smoking cessation].[戒烟的药物治疗策略]
Nervenarzt. 2011 Nov;82(11):1449-59. doi: 10.1007/s00115-010-3203-5.